WENDY HASELOFF: Open Payments
NPI 1699073999 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 14 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $403 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $97 |
| Novo Nordisk Inc | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
Products named: MOUNJARO, Rybelsus, BEXSERO, ABRYSVO, EVENITY, Veozah, Dexcom G6 Transmitter, SPRAVATO.
Industry payments across TX — which companies pay providers there.
